Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01062789
Other study ID # 09-004069
Secondary ID
Status Withdrawn
Phase Phase 0
First received January 28, 2010
Last updated May 16, 2011
Start date February 2010
Est. completion date May 2011

Study information

Verified date May 2011
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective or our study is to test the feasibility of a new optical-based breath-hold control (OBC) system for monitoring breath-hold levels and providing patient feedback during CT-guided biopsies of the lung and upper abdomen where respiratory motion is a problem.


Description:

1. Specific Aim #1: To further test the feasibility of the new OBC system for guiding accurate and reproducible breath-hold levels that correlate with internal target position in human volunteers. Hypothesis: The OBC system is as good as or better than the currently used IBC system with regard to accuracy and reproducibility of a reference breath-hold level.

2. Specific Aim #2: To compare the use of 2 optical-based belts (wrapped around the chest and abdomen) versus 1 optical-based belt (wrapped around the chest or abdomen, depending on which region expands the most during respiration) with regard to accuracy and reproducibility of a pre-determined reference breath-hold level in a subset of patients (prone and/or obese). Hypothesis: The use of 2 optical-based belts allows increased accuracy and reproducibility of a pre-determined reference breath-hold level compared with the use of only one belt in this subset of patients.

3. Specific Aim #3: To test the clinical feasibility of the new OBC system in patients undergoing CT-guided biopsy of the lung or upper abdomen where respiratory motion is a problem. Hypothesis: The OBC system is as good as or better than the currently used IBC system with regard to the accuracy and reproducibility of the reference breath-hold and ease of use.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients scheduled for a CT-guided lung or upper abdomen biopsy (including lesions in the liver, pancreas, stomach, kidneys, adrenals, spleen, or in the peritoneum at or above the level of the kidneys) on the SMH-CT-3M scanner when either Dr. Carlson or Dr. Bender are scheduled.

- Lesions will need to measure 3 cm or less in maximum dimension and cannot be affixed to the chest or abdominal wall.

Exclusion Criteria:

- Inability to cooperate with breath-holding (including cognitive impairment, poor pulmonary function that inhibits patients from being able to hold their breath for at least 10 seconds)

- Patients with bleeding diatheses (platelets < 50,000, International Normalized Ratio > 1.5, or activated partial thromboplastin time > twice normal)

- Lesions that abut the pleura or abdominal wall for a distance greater than 3 cm (these lesions were assumed to be fixed in position and less likely to be affected by respiratory motion).

- Patients with implanted medical devices (pacemakers) (this exclusion is based on the Division of Engineering Safety Review—enclosed in application)

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
Optical breath-hold control system (OBC)
The OBC system was designed to replace the IBC rubber bellows respiration sensor system that we are currently using for CT-guided lung biopsies. Unlike the IBC, the OBC is 1) unaffected by temperature changes, 2) has a linear sensitivity (for easier use and better accuracy), 3) has no pneumatic purge time when setting reference breath-hold level (reducing the chance of an inappropriate reference), 4) has no pneumatic cable that can occasionally interfere and get pinched during procedures, 5) is ambulatory (so patients can more easily familiarize themselves with the device before the procedure), 6) is capable of indicating proper fitting tension, 7) allows for easier binding (wireless pairing with other system components), and 8) is significantly less expensive (and possibly disposable).

Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability to monitor patient respiration (return of target to same anatomical position) Measured daily for each individual procedure No
Secondary Needle Placement Time Measured daily for each individual procedure No
See also
  Status Clinical Trial Phase
Withdrawn NCT00730119 - Evaluation Of The GE Monitor Product Line N/A
Not yet recruiting NCT05621642 - Telerehabilitation Based Exercise Training in Parkinson's Patients N/A
Completed NCT06354400 - Core Stabilization Training on Chest Expansion, Functional Capacity, Trunk Muscle Endurance in Hearing-Impaired Children N/A
Completed NCT01176539 - Substantial Equivalence Study for Kai Medical Non-Contact Respiratory Rate Monitor N/A
Recruiting NCT05302219 - Plethysmography Curve Variability Depending on the Breath Cycle N/A
Completed NCT03153345 - The Efficacy of Bedside Respiratory Muscle Training in Stroke Patients N/A
Recruiting NCT01324817 - Substantial Equivalence Study for Kai Medical Non-Contact Respiratory Rate Monitors for Use With Neonates N/A
Completed NCT00827905 - Substantial Equivalence Study for Kai Sensors RSpot Non-Contact Respiratory Rate Spot Check N/A
Completed NCT02946502 - Handgrip Strength Value in Predicting Mechanical Ventilation Weaning N/A
Completed NCT06247943 - Lung Protective Ventilation Strategies N/A
Completed NCT01694979 - Pelvic Floor Activity and Breathing in Women N/A
Completed NCT00893087 - Comparison of Pressure-, Flow- and Neurally Adjusted Ventilatory Assistance (NAVA)-Triggering in Pediatric and Neonatal Ventilatory Care N/A
Completed NCT00730054 - Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers Phase 1/Phase 2
Completed NCT03119103 - Functional Bed Sheet Capturing Pressure Variation and Respiratory Effort Over Time N/A
Completed NCT05886153 - Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2) N/A
Recruiting NCT03206528 - Clinical Evaluation of the Vital Signs Monitoring System (VSMS) N/A